No takers for govt reward scheme for checking spurious drugs

Image
Press Trust of India New Delhi
Last Updated : Jun 22 2014 | 1:00 PM IST
A government reward under a whistle blower scheme to encourage public participation in the detection of movement of spurious drugs in the country seem to have no takers even five years after it was launched.
According to the scheme, which was launched by the Ministry of Health and Family Welfare in August 2009, the informers would be suitably rewarded for providing information in respect of movement of spurious drugs to regulatory authorities.
A reward of up to a maximum of 20 per cent (not exceeding to Rs 25 lakh) of the total cost of consignments of fake drugs seized will be payable to any informer.
Replying to an RTI query, Central Drugs Standard Control Organisation (CDSCO) under the Health Ministry said no person has been rewarded under the scheme.
"After investigations, all the complaints received so far have been found to be fictitious. No person has accordingly been rewarded under the scheme till date," it said in reply to an RTI application filed by PTI.
As many as 572 drugs samples were declared spurious or adulterated between 2008 and July 2013.
Of these, 157 samples were reported adulterated in 2008-09, 117 during 2009-10, 95 in 2010-11, 133 during 2011-12 and 70 between April 2012 and July 2013, the reply said.
"The country's hold on international pharmaceutical market, especially the status enjoyed by it in providing high quality drugs on cheapest prices invited some unhealthy competition from various quarters.
"Internationally, the vested interests are supplying spurious medicines manufactured by them but with 'Made in India' label," said a background note on the reward scheme.
There is no dearth of good intentioned people who may wish to work for the country's interests as the whistle blowers in eradicating the menace, it said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 22 2014 | 1:00 PM IST

Next Story